MicroPort CardioFlow Medtech Corp 2022 Annual Report with Sustainability Disclosures
Company: MicroPort CardioFlow Medtech Corp
Sector: Manufacturing
Country: China
Year: 2022
Type: Annual Report with Sustainability Disclosures
Pages: 207
The report presents 2022 performance for a medical-device group focused on structural heart disease, highlighting commercialization of VitaFlow and VitaFlow Liberty in China and overseas markets. It reports revenue of 251,026 RMB'000 and 558 full-time employees, while R&D advanced a third-generation TAVI product and TMVR completed first-in-human application and six-month follow-up. The ESG report records 9,142,913 kWh of comprehensive energy consumption, 5,508.1 tCO2e of total GHG emissions, 42,828 Tons of water consumption, and no work-related fatalities in the past three years.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.